Fundraising Fox

Reveleer

Founded 2009 · 340 employees on LinkedIn · 4 known investors

Find your way into Reveleer

Reveleer provides a unified platform combining AI-powered retrieval, clinical intelligence, risk adjustment, and quality improvement tools for healthcare providers and health plans operating under value-based care models. The platform consolidates fragmented data and workflows to improve care quality, operational efficiency, and financial performance in Medicare value-based arrangements.

AI & Machine LearningDigital HealthEnterprise SoftwareHealthtech

Investors · 4

Oak HC/FTStamford
Upfront VenturesLos Angeles · $1M – $10M
Boston Millennia PartnersreportedBoston · $3M – $5M
Hercules Capital, Inc.reportedSan Mateo · $5M – $500M

In the news

How Reveleer Grew From $1 Million to $100 Million Revenue: Jay Ackerman's Value-Based Care Playbook - Founderpath Blogfounderpath.com · Oct 2025Reveleer scores $65M to scale AI-enabled data and analytics platform | MobiHealthNewsmobihealthnews.com · Feb 2024Reveleer Secures $65 Million in Financing to Drive Strategic Expansion and Enhance Product Offeringsprnewswire.com · Feb 2024Reveleer Raises $65 Million in Fundingthesaasnews.com · Dec 2021Reveleer Secures $65 Million To Expand Capabilities To Deliver End-To-End Data Analytics Platform To Healthcare Payersprweb.com · Dec 2021Reveleer Raises Capital to Fund Next Generation AI Platform to Improve Payer Population Health Complianceglobenewswire.com · Jan 2020

Frequently asked questions

What does Reveleer do?
Reveleer provides a unified platform combining AI-powered retrieval, clinical intelligence, risk adjustment, and quality improvement tools for healthcare providers and health plans operating under value-based care models. The platform consolidates fragmented data and workflows to improve care quality, operational efficiency, and financial performance in Medicare value-based arrangements.
Who are Reveleer's investors?
Reveleer's investors include Oak HC/FT, Upfront Ventures, Boston Millennia Partners, Hercules Capital, Inc..